Global Infectious Disease Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

September 2018 | 116 pages | ID: G5BD945BD9AEN
GlobalInfoResearch

Abstracts

Infectious disease therapeutics are targeting on main infectious diseases by using drugs and vaccines to prevent, control and cure them.

Scope of the Report:

This report studies the Infectious Disease Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Infectious Disease Therapeutics market by product type and applications/end industries.

Major driving factors of the global infectious disease therapeutics market are favorable reimbursement policies for infectious diseases, increasing incidence of infectious diseases, escalating consumption of anti-microbial direct acting drugs, growing geriatric population, rising awareness among population, upsurge in government investment into healthcare to eradicate infectious diseases.

The global Infectious Disease Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Infectious Disease Therapeutics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Novartis AG
• Gilead
• GlaxoSmithKline plc
• Janssen Pharmaceutical Inc.
• F. Hoffmann-La Roche Ltd.
• BioCryst Pharmaceuticals Inc.
• Merck & Co. Inc.
• Boehringer Ingelheim GmbH

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers

• Drugs
• Vaccines

Market Segment by Applications, can be divided into

• HIV/AIDS
• Influenza
• Hepatitis
• Malaria
• Tuberculosis
• Others
  
  

Contents

1 INFECTIOUS DISEASE THERAPEUTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Infectious Disease Therapeutics
1.2 Classification of Infectious Disease Therapeutics by Types
  1.2.1 Global Infectious Disease Therapeutics Revenue Comparison by Types (2017-2023)
  1.2.2 Global Infectious Disease Therapeutics Revenue Market Share by Types in 2017
  1.2.3 Drugs
  1.2.4 Vaccines
1.3 Global Infectious Disease Therapeutics Market by Application
  1.3.1 Global Infectious Disease Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 HIV/AIDS
  1.3.3 Influenza
  1.3.4 Hepatitis
  1.3.5 Malaria
  1.3.6 Tuberculosis
  1.3.7 Others
1.4 Global Infectious Disease Therapeutics Market by Regions
  1.4.1 Global Infectious Disease Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Infectious Disease Therapeutics Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Infectious Disease Therapeutics Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Infectious Disease Therapeutics Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Infectious Disease Therapeutics Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Infectious Disease Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Infectious Disease Therapeutics (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Novartis AG
  2.1.1 Business Overview
  2.1.2 Infectious Disease Therapeutics Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Novartis AG Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Gilead
  2.2.1 Business Overview
  2.2.2 Infectious Disease Therapeutics Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Gilead Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 GlaxoSmithKline plc
  2.3.1 Business Overview
  2.3.2 Infectious Disease Therapeutics Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 GlaxoSmithKline plc Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Janssen Pharmaceutical Inc.
  2.4.1 Business Overview
  2.4.2 Infectious Disease Therapeutics Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 F. Hoffmann-La Roche Ltd.
  2.5.1 Business Overview
  2.5.2 Infectious Disease Therapeutics Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 BioCryst Pharmaceuticals Inc.
  2.6.1 Business Overview
  2.6.2 Infectious Disease Therapeutics Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck & Co. Inc.
  2.7.1 Business Overview
  2.7.2 Infectious Disease Therapeutics Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Merck & Co. Inc. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Boehringer Ingelheim GmbH
  2.8.1 Business Overview
  2.8.2 Infectious Disease Therapeutics Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Boehringer Ingelheim GmbH Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET COMPETITION, BY PLAYERS

3.1 Global Infectious Disease Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Infectious Disease Therapeutics Players Market Share
  3.2.2 Top 10 Infectious Disease Therapeutics Players Market Share
3.3 Market Competition Trend

4 GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE BY REGIONS

4.1 Global Infectious Disease Therapeutics Revenue and Market Share by Regions
4.2 North America Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA INFECTIOUS DISEASE THERAPEUTICS REVENUE BY COUNTRIES

5.1 North America Infectious Disease Therapeutics Revenue by Countries (2013-2018)
5.2 USA Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

6 EUROPE INFECTIOUS DISEASE THERAPEUTICS REVENUE BY COUNTRIES

6.1 Europe Infectious Disease Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC INFECTIOUS DISEASE THERAPEUTICS REVENUE BY COUNTRIES

7.1 Asia-Pacific Infectious Disease Therapeutics Revenue by Countries (2013-2018)
7.2 China Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA INFECTIOUS DISEASE THERAPEUTICS REVENUE BY COUNTRIES

8.1 South America Infectious Disease Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE INFECTIOUS DISEASE THERAPEUTICS BY COUNTRIES

9.1 Middle East and Africa Infectious Disease Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)

10 GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SEGMENT BY TYPE

10.1 Global Infectious Disease Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Infectious Disease Therapeutics Market Forecast by Type (2018-2023)
10.3 Drugs Revenue Growth Rate (2013-2023)
10.4 Vaccines Revenue Growth Rate (2013-2023)

11 GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SEGMENT BY APPLICATION

11.1 Global Infectious Disease Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Infectious Disease Therapeutics Market Forecast by Application (2018-2023)
11.3 HIV/AIDS Revenue Growth (2013-2018)
11.4 Influenza Revenue Growth (2013-2018)
11.5 Hepatitis Revenue Growth (2013-2018)
11.6 Malaria Revenue Growth (2013-2018)
11.7 Tuberculosis Revenue Growth (2013-2018)
11.8 Others Revenue Growth (2013-2018)

12 GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE FORECAST (2018-2023)

12.1 Global Infectious Disease Therapeutics Market Size Forecast (2018-2023)
12.2 Global Infectious Disease Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Infectious Disease Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Infectious Disease Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Infectious Disease Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Infectious Disease Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Infectious Disease Therapeutics Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Infectious Disease Therapeutics Picture
Table Product Specifications of Infectious Disease Therapeutics
Table Global Infectious Disease Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Infectious Disease Therapeutics Revenue Market Share by Types in 2017
Figure Drugs Picture
Figure Vaccines Picture
Table Global Infectious Disease Therapeutics Revenue (Million USD) by Application (2013-2023)
Figure Infectious Disease Therapeutics Revenue Market Share by Applications in 2017
Figure HIV/AIDS Picture
Figure Influenza Picture
Figure Hepatitis Picture
Figure Malaria Picture
Figure Tuberculosis Picture
Figure Others Picture
Table Global Market Infectious Disease Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Infectious Disease Therapeutics Type and Applications
Table Novartis AG Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Gilead Basic Information, Manufacturing Base and Competitors
Table Gilead Infectious Disease Therapeutics Type and Applications
Table Gilead Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline plc Infectious Disease Therapeutics Type and Applications
Table GlaxoSmithKline plc Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Janssen Pharmaceutical Inc. Basic Information, Manufacturing Base and Competitors
Table Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Type and Applications
Table Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Type and Applications
Table F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table BioCryst Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Type and Applications
Table BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co. Inc. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Inc. Infectious Disease Therapeutics Type and Applications
Table Merck & Co. Inc. Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim GmbH Infectious Disease Therapeutics Type and Applications
Table Boehringer Ingelheim GmbH Infectious Disease Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Infectious Disease Therapeutics Revenue (Million USD) by Players (2013-2018)
Table Global Infectious Disease Therapeutics Revenue Share by Players (2013-2018)
Figure Global Infectious Disease Therapeutics Revenue Share by Players in 2016
Figure Global Infectious Disease Therapeutics Revenue Share by Players in 2017
Figure Global Top 5 Players Infectious Disease Therapeutics Revenue Market Share in 2017
Figure Global Top 10 Players Infectious Disease Therapeutics Revenue Market Share in 2017
Figure Global Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Infectious Disease Therapeutics Revenue (Million USD) by Regions (2013-2018)
Table Global Infectious Disease Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Infectious Disease Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Infectious Disease Therapeutics Revenue Market Share by Regions in 2017
Figure North America Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Infectious Disease Therapeutics Revenue by Countries (2013-2018)
Table North America Infectious Disease Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Infectious Disease Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Infectious Disease Therapeutics Revenue Market Share by Countries in 2017
Figure USA Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Infectious Disease Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Infectious Disease Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Europe Infectious Disease Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure UK Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure France Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure Russia Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Infectious Disease Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Infectious Disease Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Infectious Disease Therapeutics Revenue Market Share by Countries in 2017
Figure China Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure Japan Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure Korea Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure India Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Infectious Disease Therapeutics Revenue by Countries (2013-2018)
Table South America Infectious Disease Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Infectious Disease Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Infectious Disease Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure Argentina Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure Colombia Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Infectious Disease Therapeutics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Infectious Disease Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Infectious Disease Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Infectious Disease Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure UAE Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure Egypt Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure Nigeria Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Figure South Africa Infectious Disease Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Infectious Disease Therapeutics Revenue (Million USD) by Type (2013-2018)
Table Global Infectious Disease Therapeutics Revenue Share by Type (2013-2018)
Figure Global Infectious Disease Therapeutics Revenue Share by Type (2013-2018)
Figure Global Infectious Disease Therapeutics Revenue Share by Type in 2017
Table Global Infectious Disease Therapeutics Revenue Forecast by Type (2018-2023)
Figure Global Infectious Disease Therapeutics Market Share Forecast by Type (2018-2023)
Figure Global Drugs Revenue Growth Rate (2013-2018)
Figure Global Vaccines Revenue Growth Rate (2013-2018)
Table Global Infectious Disease Therapeutics Revenue by Application (2013-2018)
Table Global Infectious Disease Therapeutics Revenue Share by Application (2013-2018)
Figure Global Infectious Disease Therapeutics Revenue Share by Application (2013-2018)
Figure Global Infectious Disease Therapeutics Revenue Share by Application in 2017
Table Global Infectious Disease Therapeutics Revenue Forecast by Application (2018-2023)
Figure Global Infectious Disease Therapeutics Market Share Forecast by Application (2018-2023)
Figure Global HIV/AIDS Revenue Growth Rate (2013-2018)
Figure Global Influenza Revenue Growth Rate (2013-2018)
Figure Global Hepatitis Revenue Growth Rate (2013-2018)
Figure Global Malaria Revenue Growth Rate (2013-2018)
Figure Global Tuberculosis Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Infectious Disease Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Infectious Disease Therapeutics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Infectious Disease Therapeutics Revenue Market Forecast (2018-2023)
Figure Europe Infectious Disease Therapeutics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Infectious Disease Therapeutics Revenue Market Forecast (2018-2023)
Figure South America Infectious Disease Therapeutics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Infectious Disease Therapeutics Revenue Market Forecast (2018-2023)